Doc Code: TRACK1.REQ
`DocumentDescription: TrackOne Request
`
`PTO/AIA/424 (04-14)
`
`CERTIFICATION AND REQUEST FOR PRIORITIZED EXAMINATION
`UNDER 37 CFR 1.102(e) (Page 1 of 1)
`
`Ammar Al-Al
`
`PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`APPLICANT HEREBY CERTIFIES THE FOLLOWING AND REQUESTSPRIORITIZED EXAMINATION FOR
`THE ABOVE-IDENTIFIED APPLICATION.
`
`forms are submitted.
`
`1. The processing fee set forth in 37 CFR 1.17(i)(1) and the prioritized examination fee set forth in
`37 CFR 1.17(c) have beenfiled with the request. The publication fee requirement is met
`becausethat fee, set forth in 37 CFR 1.18(d), is currently $0. The basic filing fee, search fee,
`and examination fee are filed with the request or have been already been paid.
`| understand
`that any required excess claims fees or application size fee must be paid for the application.
`
`| understand that the application may not contain, or be amendedto contain, more than four
`independentclaims, more thanthirty total claims, or any multiple dependent claims, and that
`any request for an extension oftime will cause an outstanding Track | request to be dismissed.
`
`3. The applicable box is checked below:
`
`Original Application (Track One)
`
`- Prioritized Examination under § 1.102(e)(1
`
`(a) The application is an original nonprovisional utility application filed under 35 U.S.C. 111(a).
`This certification and requestis being filed with the utility application via EFS-Web.
`
`(b) The application is an original nonprovisional plant application filed under 35 U.S.C. 111(a).
`This certification and requestis being filed with the plant application in paper.
`
`An executed inventor's oath or declaration under 37 CFR 1.63 or 37 CFR 1.64 for each
`inventor, or the application data sheet meeting the conditions specified in 37 CFR 1.53(f)(3)(i) is
`filed with the application.
`
`Request for Continued Examination - Prioritized Examination under
`
`A request for continued examination has beenfiled with, or prior to, this form.
`If the application is a utility application, this certification and requestis being filed via EFS-Web.
`ili. The application is an original nonprovisionalutility application filed under 35 U.S.C. 111(a), oris
`a national stage entry under 35 U.S.C. 371.
`iv. This certification and requestis being filed prior to the mailing of a first Office action responsive
`to the requestfor continued examination.
`No prior request for continued examination has been granted prioritized examination status
`under 37 CFR 1.102(e)(2).
`
`signature/Yarom Kesler/
`Name
`yvarom D. Kesler
`(Print/Typeq)
`
`pate 2020-03-30
`Practitioner
`57046
`Registration Number
`
`This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certifications.
`Note:
`
`Submit multiple forms if more than one signature is required.*
`*Total of 1
`
`1
`
`APPLE 1002
`
`1
`
`APPLE 1002
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2)
`furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or
`patent.
`If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or abandonmentof the
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`be disclosed to the Department of Justice to determine whether disclosure of these records is required by the
`Freedom of Information Act.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`A record in this system of records maybe disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`the Member with respect to the subject matter of the record.
`A record in this system of records maybe disclosed, as a routine use, to a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to comply
`with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may bedisclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`Arecord in this system of records may bedisclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(Cc)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSAas part of that agency’s
`responsibility to recommend improvements in records managementpractices and programs, under authority of
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records for this purpose, and any other relevant (7.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may bedisclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record
`wasfiled in an application which became abandonedor in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomesawareofa violation or potential violation of law or regulation.
`
`2
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OME control number.
`
`. Attorney Docket Number|MAS.1007C7ge
`
`
`Application Data Sheet 37 CFR 1.76
`—
`
`Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`The application data sheetis part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`document may be printed and included in a paperfiled application.
`
`Secrecy Order 37 CFR 5.2:
`
`0 Portions or all of the application associated with this Application Data Sheet mayfall under a Secrecy Order pursuantto
`
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may notbefiled electronically.)
`
`Remove
`
`
`Inventor Information:
`
`Inventor
`,
`
`
`Legal Name
`
`Residence Information (Select One)
`
`e US Residency
`
`Non US Residency
`
`Active US Military Service
`
`Mailing Addressof Inventor:
`| fpost2 Via Bella
`
`Address 1
`
`
`
`
`
`
`
`Country i
`
`
`Address 2
`
`| A
`State/Province
`| an Juan Capistrano
`
`US
`
`Postal Code
`92675
`
`All
`Inventors Must Be Listed - Additional
`Inventor Information blocks may be
`
`generatedwithin this form by selecting the Add button. Ade
`
`CorrespondenceInformation:
`
`
`Enter either Customer Number or complete the CorrespondenceInformation section below.
`
`For further information see 37 CFR 1.33(a).
`
`[|An Addressis being provided for the correspondenceInformation of this application.
`
`
`| B4735
`Customer Number
`Email Address
`
`
`
`|ffling@knobbe.com Add Email Remove Email
`
`
`
`Application Information:
`
`
`
`
`
`
`
`
`
`
`
`
`
`Total Numberof Drawing Sheets (if any)
`
`Suggested Figure for Publication (if any)
`
`EFS Web 2.2.13
`
`3
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
` Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number|MAS.1007C7
`
`Application Number
`
`
` Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`Filing By Reference:
`
`
`Only complete this section whenfiling an application by reference under 35 U.S.C. 111(c) and 37 CFR 1.57(a). Do not complete this sectionif
`application papers including a specification and any drawingsare beingfiled. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information’ and “Foreign Priority Information’).
`
`For the purposesof a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`
`i
`
`Application numberofthe previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country
`
`
`
`po
`
`
`
`
`Publication Information:
`
`[_] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`
`
`Request Not to Publish. | hereby requestthat the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not andwill not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months afterfiling.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
`
`
`Please Select One:
`Customer Number
`
`e@ Customer Number
`
`US Patent Practitioner
`
`©) Limited Recognition (37 CFR 11.9)
`
`
`
`
`
`
`Domestic Benefit/National Stage Information:
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the “Application Number’field blank.
`
`
`Prior Application Status
`Ee
`
`
`Filing or 371(c) Date
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`Application Number
`
`Continuity Type
`
`
`
`EFS Web 2.2.13
`
`
`
`4
`
`

`

` by selecting the Add button.
`
`
`
`
`
`
`
`Prior Application Status
`Issue Date
`Prior Application
`Application
`Continuity Type
`Filing Date
`(YYYY-MM-DD)
`Patent Number
`Number
`Number
`(YYYY-MM-DD)
`16/532065
`| continuation of
`+ |[167226249
`2018-12-19
`10470695
`|b 0419-11-12
`Remove
`
`Prior Application StatusPatented==
`
`Application
`_
`Prior Application
`Filing Date
`Issue Date
`Number
`Continuity Type
`Number
`(YYYY-MM-DD)
`Patent Number
`(YYYY-MM-DD)
`16/226249
`[Continuation of
`+ 15/195199
`
` 2016-06-28
`i!0448871
`bot9-10-22
` Remove
`Filing or 371(c) Date
`(YYYY-MM-DD)
`|po1s-07-02
`
`
`
` Attorney Docket Number
`
`Application Number
`
`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`MAS.100/7C7
`Application Data Sheet 37 CFR 1.76
`
`
`
`Title of Invention
`PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`
`
`Prior Application Statusa
`
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing or 371(c) Date
`(YYYY-MM-DD}
`
`6/791963
`
`| ontinuationof= 16/532065
`
`Patented
`
`|2019-08-05
`
`Remove
`
`
`
`
`
`
`Prior Application Status
`
`
`Application Number
`5/195199
`
`Continuity Type
`| laims benefit of provisional
`
`Prior Application Number
`~| 62/188430
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55. Whenpriority is claimed to a foreign application
`thatis eligible for retrieval under the priority document exchange program (PDX)! the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55{i)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority applicationis filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`
`
`Remove
`Country!
`Application Number
`Access Code! (if applicable)
`
`
`Filing Date (YYYY-MM-DD)
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Add
`
`
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`EFS Web 2.2.13
`
`5
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
` Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number|MAS.1007C7
`
`Application Number
`
`
`Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effectivefiling date on or after March
`[] 16, 2013.
`NOTE: Byproviding this statement under 37 CFR 1.55 or 1.78, this application, withafiling date on or after March
`16, 2013, will be examined underthe first inventor to file provisions of the AIA.
`
`
`
`
`
`EFS Web 2.2.13
`
`6
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`icati
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`
`
`Authorization or Opt-Out of Authorization to Permit Access:
`
`When this Application Data Sheet is properly signed and filed with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed (see
`paragraphA in subsection 1 below) and the European Patent Office (EPO) access to any search results from the instant
`application (see paragraph B in subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of the
`authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIAL filing of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s). Instead, Form PTO/SB/39 or PTO/SB/69 must be used as appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s}
`
`A. Priority Document Exchange (PDX) - Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent Office
`(JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People’s Republic of
`China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual property office
`participating with the USPTOin a bilateral or multilateral priority document exchange agreementin which a foreign
`application claiming priority to the instant patent application is filed, access to: (1) the instant patent application-as-filed
`andits related bibliographic data, (2) any foreign or domestic application to which priority or benefit is claimed by the
`instant application and its related bibliographic data, and (3) the date offiling of this Authorization. See 37 CFR 1.14(h)
`(1).
`
`
`
`
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is checked,
`the undersigned hereby grants the USPTO authority to provide the EPO access to the bibliographic data and search
`results from the instant patent application when a European patent application claiming priority to the instant patent
`application is filed. See 37 CFR 1.14(h)(2).
`
`The applicant is reminded that the EPO’s Rule 141(1}) EPC (European Patent Convention) requires applicants to submit a
`copy of search results from the instant application without delay in a European patent application that claimspriority to
`the instant application.
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s}
`
`[|]
`
`A. Applicant DOES NOTauthorize the USPTOto permit a participating foreign IP office access to the instant
`application-as-filed.
`If this box is checked, the USPTOwill not be providing a participating foreign IP office with
`any documents and information identified in subsection 1A above.
`
`[_]
`
`B. Applicant DOES NOT authorize the USPTO to transmit to the EPO any search results from the instant patent
`application. If this box is checked, the USPTO will not be providing the EPO with search results from the instant
`application.
`NOTE: Oncethe application has published oris otherwise publicly available, the USPTO mayprovide accessto the
`application in accordance with 37 CFR 1.14.
`
`EFS Web 2.2.13
`
`7
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`Applicant Information:
`
`
`Providing assignmentinformation in this section does not substitute for compliance with any requirementof part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`
`H
`Applicant
`
`If the applicantis the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be providedin this section is the name and addressof the legal representative whois the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventoris under an obligation to assign the invention, or person
`whootherwise shows sufficient proprietary interest in the matter whois the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventoris obligated to assign, or person whootherwise shows sufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`
`
`
`Joint Inventor
`
`Person to whom theinventoris obligated to assign.
`Person who showssufficient proprietary interest
`
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventoris:
`
`
`
`@ Assignee
`
`Legal Representative under 35 U.S.C. 117
`
`Name of the Deceased or Legally Incapacitated Inventor:
`
`x]
`If the Applicant is an Organization check here.
`
`Organization Name
`AASIMO CORPORATION
`
`
`
`
`
`
`
`
`Mailing Address Information For Applicant:
`
`
`
`Address 2
`city
`
`Fees staterrrovince[fea
`
`Phone Number + FaxNumber
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Email Address
`
`
`
`Assignee Information including Non-Applicant Assignee Information:
`
`
`Providing assignmentinformation in this section does not substitute for compliance with any requirementof part 3 ofTitle
`37 of CFR to have an assignment recorded by the Office.
`
`
`EFS Web 2.2.13
`
`8
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
` Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number|MAS.1007C7
`
`Application Number
`
`
`Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`
`
`ff
`Assignee
`
`Complete this section if assignee information, including non-applicant assigneeinformation, is desired to be included on the patent
`application publication. An assignee-applicant identified in the "Applicant Information” section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`patent application publication.
`
`Remove
`
`
`
`
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`
` Prefix
`Given Name
`
`
`
`
`
`
`
`
`Signature:
`
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However, if this Application
`
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checked in
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access” section, then this form must
`also be signed in accordancewith 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (e.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or more joint inventor-applicants who have been given
`power of attorney (e.g., see USPTO Form PTO/AIA/81) on behalf of all jcint inventor-applicants.
`See 37 CFR 1.4(d) for the manner of making signatures and certifications.
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 1
`i
`Address 2
`cy [J icrrovines[[S—~*d
`countyi
`JT—~iesticode
`Phone Number
`Fax Number
`
`
`Email Address
`
`|
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`.
`selecting the Add button.
`
`Add
`
`
`Signature
`Jarom Kesler/
`Date (YYYY-MM-DD)|
`2020-03-30
`
`
` First Name
`
`[faono—[tasinare
`Registration Number |
`Additional Signature may be generated within this form by selecting the Add button.
`Add
`
`EFS Web 2.2.13
`
`9
`
`

`

`PTOVAIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`— Title of Invention|PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS
`
`Application Data Sheet 37 CFR 1.76
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.13
`
`10
`
`10
`
`

`

`Privacy Act Statement
`
`application or patent. Accordingly, pursuant to the requirementsof the Act, please be advised that: (1) the general authority for the collection ofthis information
`is 35 U.S.C. 2(b)(2}; (2) furnishing ofthe informationsolicited is voluntary; and (3) the principal purpose for which the informationis used by the U.S. Patent and
`Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S.
`Patent and Trademark Office may not be able to process and/or examine your submission, which mayresult in termination of proceedings or abandonmentof
`the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom ofInformation Act (5 U.S.C. 552) and the Privacy
`Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the DepartmentofJustice to determine whether the Freedom of
`Information Act requires disclosure of these records.
`
`Arecord from this system of records may be disclosed,as a routineuse, in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including disclosures to opposing counselin the course of settlement negotiations.
`
`Arecordin this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an individual, to whom
`the record pertains, when the individual has requested assistance from the Memberwith respect to the subject matterof the record.
`
`A record in this system of records maybe disclosed, as a routine use, to a contractorof the Agency having need for the information in order to perform
`acontract. Recipients of information shall be required to comply with the requirementsof the Privacy Act of 1974, as amended, pursuant to 5 U.S.C.
`352a(m).
`
`Arecord related to an International Application filed under the Patent Cooperation Treaty in this system of records maybedisclosed, as a routine use,
`to the International Bureau of the WorldIntellectual Property Organization, pursuant to the Patent CooperationTreaty.
`
`Arecord in this system of records may bedisclosed,as a routine use, to another federal agency for purposesof National Security review (35 U.S.C. 181)
`and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an
`inspection of records conducted by GSAas part of that agency's responsibility to recommend improvementsin records managementpractices and
`programs, underauthority of 44 U.S.C. 2904 and 2906. Such disclosure shall be madein accordance with the GSA regulations governing inspection of
`records for this purpose, and any otherrelevant(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about
`individuals.
`
`Arecord from this system of records may be disclosed,as a routine use, to the public after either publication of the application pursuantto 35 U.S.C.
`122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use,
`to the public if the record wasfiled in an application which became abandoned orin which the proceedings were terminated and which applicationis
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`Arecord from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency,if the USPTO becomes
`awareofa violation or potential violation of law or regulation.
`
`
`
` ThePrivacy Act of 1974 (P.L. 93-579) requires that you be givencertain information in connection with your submissionof the attached form related to a patent
`
`
`EFS Web 2.2.13
`
`11
`
`11
`
`

`

`
`
`
`
`Lnnderthe Papervork Redoeliest Act of 4335, ra strains are required te resganc tn a
`
`
`DECLARATION (37 CFR 1.83) FOR UTILITY OR DESIGN APPLICATION USING AN
`APPLICATION DATA SHEET (37 CFR 478)
`
`
`
`
`TRie af
`ADVANCED PULSE OAIMETRY SENSOR
`
`invention
`
`
` eciare t
`
`
`
`
`
`The atiached application, or
`
`TEfTSS 199
`
`eo United States apmlication ar PCT international ap
`an ruraber
`
`ty
`Mey
`fed on VUNG 28, O18
`
`sade aor aulhonzed te be made by nis.
`
`
`
`
`ie irt this declarationis punishable under 18 LES.C. 1g04
`
`:
`=8reaby scknawiedge that anyve
`ine Or yopris
`
`WARNING:
`
`rane
`
`Note: An application data sheet (PTOVSEV14 or equivelent), including naming the entire imventive enilly, must ancampany ihis farmor raust have
`
`
`
`joint iwvenian of a aimed invenhan in the
`
`
`
`
`
`
`
`Patitionervapplicant is cautioned fo avoid subrnitting personal inforreation in documents fllad in a patent apoiication that mey
`Personal information such as social security rurnbers, Gank aecount numbers, ar credit card murab
`
`
`
`
`ait card authorization form BE©-2038 aubmitied far payment punposes) is never required by The US
`fother than a chac
`
`
`to suppart 8 setition cr an application. vai InformationisIncluded in documents submitted to tha USPTO,ff this type of
`
`
`
`
`pei nersigaplicanis should consider redacting such personal information fram the documents Delors submitting thera to the
`
`
`
`USPTO. Patilaner/applicant is advised that the record of a patentapplication ig availibleto the pubke after publication of the
`neiuniess @ noreoublication racuest in cofmphance with
`3Y GFR P2iatal is eaes inthe‘application) or issusnce af &
`
`
`
`
`
`
`
`
`
`natet
`. Furthermore, the record fram an abe
`S applicalian may also be avadabie tothe pubhe ifthe anplicatian is
`
`referenced in a published applicalion ar an issued‘patent ¢sae 3¥ CFR 14). ShacksSond reds cand authorigatior7 forms
`
`
`
`PTO-2036 submitted for payniant purposes
`are rot retained in the applic tion fie and therefore are not sublicly
`availadia.
`
`
`
`
`
`
`LEGAL NAN = OF INVENTOR
`
`
`
`
`
`
`_ Aryriar Al-AH
`Date> (Qotional) :
`
`
`
`beenpreviouslyfled, Useanadditional-”
`Wiformforeachsdditienalinventor,
`
`=
`
`oc
`Patent and Trademark Otice. U.S. Departnent a! :
`
`THIS ASDRESS. SEND TO: Commissioner far Patents, PLO, Box 1455, Alenand a, VAR 229413
`3
`Y
`
`
`you naed sssisisace in completing the ta, Salt ARO TOYS and s
`
`12
`
`12
`
`

`

`Doc Code: PA..
`PTO/AIA/82A (07-13)
`Approved for use through 03/31/2021. OMB 0651-0035
`DocumentDescription: Power of Attorney
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unlessit displays a valid OMB control number.
`
`TRANSMITTAL FOR POWER OF ATTORNEY TO ONE OR MORE
`REGISTERED PRACTITIONERS
`
`NOTE: This form is to be submitted with the Power of Attorney by Applicant form (PTO/AIA/82B)to identify the applic